314 related articles for article (PubMed ID: 27029061)
21. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A.
Shou T; Yang H; Lv J; Liu D; Sun X
Mol Med Rep; 2019 Feb; 19(2):1049-1055. PubMed ID: 30483744
[TBL] [Abstract][Full Text] [Related]
23. Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation.
Tanaka Y; Yano H; Ogasawara S; Yoshioka S; Imamura H; Okamoto K; Tsuneoka M
Mol Cell Biol; 2015 Dec; 35(24):4170-84. PubMed ID: 26416883
[TBL] [Abstract][Full Text] [Related]
24. Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma.
Wang J; Li T; Li X; Zhang Y; Wang X
BMC Urol; 2021 Aug; 21(1):108. PubMed ID: 34391411
[TBL] [Abstract][Full Text] [Related]
25. Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3.
Lu B; Wei J; Zhou H; Chen J; Li Y; Ye L; Zhao W; Wu S
Cell Death Dis; 2022 Jun; 13(6):547. PubMed ID: 35697678
[TBL] [Abstract][Full Text] [Related]
26. Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1.
Jiang H; Zhou C; Zhang Z; Wang Q; Wei H; Shi W; Li J; Wang Z; Ou Y; Wang W; Wang H; Zhang Q; Sun W; Sun P; Yang S
Nat Commun; 2020 Oct; 11(1):5129. PubMed ID: 33046710
[TBL] [Abstract][Full Text] [Related]
27. The transcription factor c-Fos coordinates with histone lysine-specific demethylase 2A to activate the expression of cyclooxygenase-2.
Lu S; Yang Y; Du Y; Cao LL; Li M; Shen C; Hou T; Zhao Y; Wang H; Deng D; Wang L; He Q; Zhu WG
Oncotarget; 2015 Oct; 6(33):34704-17. PubMed ID: 26430963
[TBL] [Abstract][Full Text] [Related]
28. A molecular threading mechanism underlies Jumonji lysine demethylase KDM2A regulation of methylated H3K36.
Cheng Z; Cheung P; Kuo AJ; Yukl ET; Wilmot CM; Gozani O; Patel DJ
Genes Dev; 2014 Aug; 28(16):1758-71. PubMed ID: 25128496
[TBL] [Abstract][Full Text] [Related]
29. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
[TBL] [Abstract][Full Text] [Related]
30. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
[TBL] [Abstract][Full Text] [Related]
31. ATM-mediated KDM2A phosphorylation is required for the DNA damage repair.
Cao LL; Wei F; Du Y; Song B; Wang D; Shen C; Lu X; Cao Z; Yang Q; Gao Y; Wang L; Zhao Y; Wang H; Yang Y; Zhu WG
Oncogene; 2016 Jan; 35(3):301-13. PubMed ID: 25823024
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the notch signaling pathway on the role of estrogen in angiogenesis.
Soares R; Balogh G; Guo S; Gärtner F; Russo J; Schmitt F
Mol Endocrinol; 2004 Sep; 18(9):2333-43. PubMed ID: 15192074
[TBL] [Abstract][Full Text] [Related]
33. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
35. Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties.
Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Rafii S; Rafii A
PLoS One; 2014; 9(11):e112424. PubMed ID: 25380486
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of KDM2A inhibits proliferation associated with TGF-β expression in HEK293T cell.
Xu WH; Liang DY; Wang Q; Shen J; Liu QH; Peng YB
Mol Cell Biochem; 2019 Jun; 456(1-2):95-104. PubMed ID: 30604066
[TBL] [Abstract][Full Text] [Related]
37. Production of ROS by Gallic Acid Activates KDM2A to Reduce rRNA Transcription.
Tanaka Y; Obinata H; Konishi A; Yamagiwa N; Tsuneoka M
Cells; 2020 Oct; 9(10):. PubMed ID: 33050392
[TBL] [Abstract][Full Text] [Related]
38. Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.
Huang Y; Liu Y; Yu L; Chen J; Hou J; Cui L; Ma D; Lu W
Tumour Biol; 2015 Jan; 36(1):271-8. PubMed ID: 25245333
[TBL] [Abstract][Full Text] [Related]
39. NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.
Kottakis F; Foltopoulou P; Sanidas I; Keller P; Wronski A; Dake BT; Ezell SA; Shen Z; Naber SP; Hinds PW; McNiel E; Kuperwasser C; Tsichlis PN
Cancer Res; 2014 Jul; 74(14):3935-46. PubMed ID: 24853546
[TBL] [Abstract][Full Text] [Related]
40. RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.
Kong Y; Zou S; Yang F; Xu X; Bu W; Jia J; Liu Z
Cancer Lett; 2016 Oct; 381(1):138-48. PubMed ID: 27497248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
